The Biotech Investor: How to Profit from the Coming Boom in Biotechnology

Tom Abate (Author)
Available

Description

"Tom Abate's reporting on biotechnology has always been ahead of the times. The Biotech Investor tackles the brave new world of stem cells, genomics, and clones and comes up a winner." --Thom Calandra, editor in chief, CBS MarketWatch

In The Biotech Investor, San Francisco Chronicle biotechnology reporter Tom Abate explains the science, finances, time horizon, and technological and commercial potential of this burgeoning industry.
Abate provides guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He shares strategies for
- tracking the effect of breaking news and the NASDAQ
- anticipating drug trial announcements and FDA approvals
- assessing the potential market, patent rights, and distribution deals for a drug
He looks beyond medicine to biotech-related opportunities in everything from agriculture to jean manufacturing to software development. The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.

Product Details

Price
$23.00  $21.16
Publisher
St. Martins Press-3PL
Publish Date
January 01, 2004
Pages
304
Dimensions
5.5 X 0.81 X 8.54 inches | 0.85 pounds
Language
English
Type
Paperback
EAN/UPC
9780805075083
BISAC Categories:

Earn by promoting books

Earn money by sharing your favorite books through our Affiliate program.

Become an affiliate

About the Author

One of the nation's most influential observers of the biotechnology industry, award-winning technology and health-care reporter Tom Abate writes the weekly "BioScope" column for the San Francisco Chronicle. He lives in San Leandro, California.